期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

NT-pro-BNP在治疗ACS中的应用和意义 被引量：9

在线阅读 下载PDF
导出
摘要 脑钠肽(BNP)是一种由心脏分泌的神经内分泌激素,最早被发现在心室壁压力增加时大量分泌,因而在诊断治疗心衰、判断心衰患者预后中广泛被应用。近来的研究认为BNP在冠心病领域中也有重大的应用意义。在血液中检测BNP水平的变化能独立、有效、敏感地判断ACS(急性冠脉综合征)患者短期和长期的预后,并且能指导治疗方法的选择,判断疗效。NT-pro-BNP(N末端脑钠肽前体)与BNP有相似的生理功能,但前者较后者在临床应用中更具有优点,因而逐渐取代后者。
作者 傅燕琳
机构地区 复旦大学附属中山医院上海市心血管病研究所
出处 《中国实用医药》 2010年第4期55-57,共3页 China Practical Medicine
关键词 BNP NT-PRO-BNP ACS
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献7

  • 1Johannes Steiner, Maya Guglin. BNP or NTproBNP a clinician' s perspective. International Journal of Cardiology,2008,129:5-14.
  • 2Stephen D. Wiviotta Pathophysiology, prognostic significance and clinical utility of B-type natriuretic peptide in acute coronary syndromes. Clinica Chimica Acta,2004,346 : 119-128.
  • 3James A de Lemos. B-type natriuretic peptide in cardiovascular disease. Lancet,2003,362: 316-22.
  • 4David A, Morrow. Evaluation of B-Type NatriureticPeptide for Risk Assessment inUnstableAngina/Non-ST-Elevation Myocardial InfarctionB-Type Natriuretic Peptide and Prognosis in TACTICS-TIMI 18 Journal of the American College of Cardiology, 2003,41:1853.
  • 5Stefan K. James. N-Terminal Pro-Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO) -Ⅳ Substudy. Circulation,2003,108:275-281.
  • 6EULER R. F. MANENTI. Prognostic value of serum biomarkers in association with TIMI risk score for acute coronary syndromes. Clin. Cardiol,2006:29.
  • 7Rudolf Jarai. N-terminal pro-brain natriuretic peptide in relation to inflammation, myocardial necrosis, and the effect of an invasive strategy in unstable coronary artery disease. J Am Coll Cardiol, 2003 ;42:1909 -1916. Journal of the American College of Cardiology Volume 44, Issue 9, 2 November 2004, Page 1932.

同被引文献53

  • 1李真,王娇,王燕娥,朱皓,刘俊.年轻急性心肌梗死患者的危险因素分布特点[J].中华临床医师杂志（电子版）,2010,4(6):825-828. 被引量：3
  • 2Peter Honerjager.Pharmacology of bipyridine phosphodiesterase inhibitors[J].Am heart J,1991,121:1939-1947.
  • 3Anderson JL.Hemodynamic and clinical benefits with intraveneus milrinone in severe chronic heart failure.Resurts of a multi center study in the United tates[J].Am Heart J,1991,121:1958-1964.
  • 4中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.115-119.
  • 5Toth M, Vuofinen KH, Vuolteenaho O, et al. Hypoxia st imulates release of ANP an d BNP from perfused rat vent rieular myocardi- um [J]. Am J Physiol, 1994, 266:H1572.
  • 6Blankberg S, MeQueen M J, Smieja M, et al. Comparative impact of multiple biomarkers and N-terminal probmin natfiuretic peptide in the context of conventional risk factors for the prediction of recur- rent cardiovascular events in the heart outcomes prevention evalua- tion (HOPE) study[ J ]. Circulation, 2006,114:201-208.
  • 7Jernberg T, Stridsberg M, Verge P, et al. N-terminai probrain natri- uretic peptide on admission for early risk stratification of patients with chest pain and no ST-segment elebation[ J]. J Am Coll Cardi- o1,2002 ;40:437-445.
  • 8Heesehen C, Hamm CW, Mitrovic V, et al. N-terminal pro-B-type natriurctic peptide levels for dynamic risk stratification of patients with acute coronary syndromes [ J ]. Circulation, 2004,110 : 3206- 3212.
  • 9Euler R F, MANENT 1. Prognostic value of serum b iomarkers ion with TIMI risk score for acute coronary syndromes[ J]. Clin Cardi- o1,2006 ,29 :354.
  • 10张文武.急诊内科学[M].3版.北京:人民卫生出版社,2012:368.

引证文献9

二级引证文献46

中国实用医药
2010年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部